Table 1.
Age (Range) | CRC | LAC | MEL | ||
---|---|---|---|---|---|
MSI | Driver-Free | ||||
68 (26–88) | 62 (37–80) | 66 (55–78) | 65 (37–90) | ||
Gender | Male | 23 | 21 | 9 | 14 |
Female | 32 | 9 | 3 | 14 | |
Total | 55 | 30 | 12 | 28 | |
Specimen type | Resection | 55 | 23 | 8 | 15 |
Biopsy | 0 | 6 | 2 | 13 | |
Cytologic sample | 0 | 1 | 2 | 0 | |
Total | 55 | 30 | 12 | 28 | |
Lesion type | Primary tumour | 55 | 21 | 10 | 21 |
Metastatic deposit | 0 | 9 | 2 | 7 | |
Total | 55 | 30 | 12 | 28 | |
Stage | I | 14 | 0 | 3 * | 0 |
II | 27 | 3 | 0 | 2 | |
III | 11 | 10 | 2 | 12 | |
IV | 3 | 17 | 7 | 14 | |
Total | 55 | 30 | 12 | 28 |
MSI—microsatellite instability; CRC—colorectal cancer; LAC—lung adenocarcinoma; MEL—melanoma. * Molecular test performed on second primary tumours.